Just released from FDAnews — Investigations Operations Manual 2014 — the FDA’s own internal guidance on how to inspect a drug or device company. Know what the investigators look for — before they even get there.
Countries such as the UK, France, Poland, Sweden and Italy offer tremendous advantages for drug and device developers. But, conducting clinical trials in the EU can be challenging and unpredictable.
Now you can learn the inside story of how to successfully navigate development faster in the EU — without running into compliance problems or triggering costly delays.
CD and Transcript Only - July 29, 2010
You'll receive an audio CD and a written transcript of the entire Virtual Summit, including the Q&A period and all presentation materials, four weeks after the session.